These shares are having a good start to the week. But why? The post Why ALS, Life360, Nuix, and Sovereign Metals shares are ...

Goldman Sachs has good things to say about this share. The post Top broker says this ASX 200 share is a buy for a 10%+ return ...

Matt Van Tuinen, the BNP Paribas Open media director who was diagnosed with ALS in April, says his heart is full when he's in ...

A former New Orleans Police Department sergeant affectionately known as the “dancing cop” has died after falling ill from ALS ...

Recent studies have highlighted a link between amyotrophic lateral sclerosis (ALS) and gut microbiota. This prospective study aimed to evaluate the effects of electroacupuncture combined with Chinese ...

Scientists used positron emission tomography (PET) with edaravone, a drug used to treat ALS, to detect oxidative stress, which leads to brain damage, offering a clear path to detecting neurological ...

ALS Walk in Elbow is on the Horizon and registration is finally open. On Sunday, June 8, the walk starts from the Elbow ...

Ohio reviews HB 24 to expand Medigap for ESRD and ALS patients under 65, potentially alleviating financial burdens.

Tiziana is seeking FDA clearance for a Phase 2 clinical trial testing the safety and efficacy of its foralumab nasal spray in ...

Sarasota-Manatee partnership offers free hearing support; job fairs in Bradenton, Sarasota; Goodwill opens LWR outlet; arts ...

The intrinsically disordered proteins (IDPs) do not attain a stable secondary or tertiary structure and rapidly change their conformation, making structure prediction particularly challenging.

There’s no cure and the statistics are discouraging, but there’s a mobile app that’s creating hope for people living with ALS and their caregivers.